Alliston Tamara
Department of Orthopaedic Surgery, University of California San Francisco, 513 Parnassus Avenue, Room S-1155, San Francisco, CA, 94143-0514, USA,
Curr Osteoporos Rep. 2014 Sep;12(3):366-75. doi: 10.1007/s11914-014-0213-4.
The ability of bone to resist fracture is determined by the combination of bone mass and bone quality. Like bone mass, bone quality is carefully regulated. Of the many aspects of bone quality, this review focuses on biological mechanisms that control the material quality of the bone extracellular matrix (ECM). Bone ECM quality depends upon ECM composition and organization. Proteins and signaling pathways that affect the mineral or organic constituents of bone ECM impact bone ECM material properties, such as elastic modulus and hardness. These properties are also sensitive to pathways that regulate bone remodeling by osteoblasts, osteoclasts, and osteocytes. Several extracellular proteins, signaling pathways, intracellular effectors, and transcription regulatory networks have been implicated in the control of bone ECM quality. A molecular understanding of these mechanisms will elucidate the biological control of bone quality and suggest new targets for the development of therapies to prevent bone fragility.
骨骼抵抗骨折的能力由骨量和骨质量共同决定。与骨量一样,骨质量也受到精细调控。在骨质量的诸多方面中,本综述聚焦于控制骨细胞外基质(ECM)物质质量的生物学机制。骨ECM质量取决于ECM的组成和结构。影响骨ECM矿物质或有机成分的蛋白质和信号通路会影响骨ECM的材料特性,如弹性模量和硬度。这些特性也对成骨细胞、破骨细胞和骨细胞调节骨重塑的通路敏感。几种细胞外蛋白质、信号通路、细胞内效应器和转录调控网络都与骨ECM质量的控制有关。对这些机制的分子层面理解将阐明骨质量的生物学调控,并为开发预防骨脆性的治疗方法提供新靶点。